These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8584480)

  • 1. Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength.
    Akers MJ; Milton N; Byrn SR; Nail SL
    Pharm Res; 1995 Oct; 12(10):1457-61. PubMed ID: 8584480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of frozen solutions of glycine.
    Chongprasert S; Knopp SA; Nail SL
    J Pharm Sci; 2001 Nov; 90(11):1720-8. PubMed ID: 11745729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase transitions of glycine in frozen aqueous solutions and during freeze-drying.
    Pyne A; Suryanarayanan R
    Pharm Res; 2001 Oct; 18(10):1448-54. PubMed ID: 11697471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration.
    Varshney DB; Kumar S; Shalaev EY; Sundaramurthi P; Kang SW; Gatlin LA; Suryanarayanan R
    Pharm Res; 2007 Mar; 24(3):593-604. PubMed ID: 17245648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions.
    Sundaramurthi P; Suryanarayanan R
    Pharm Res; 2011 Feb; 28(2):374-85. PubMed ID: 20927571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine crystallization during spray drying: the pH effect on salt and polymorphic forms.
    Yu L; Ng K
    J Pharm Sci; 2002 Nov; 91(11):2367-75. PubMed ID: 12379921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine phases formed from frozen aqueous solutions: revisited.
    Surovtsev NV; Adichtchev SV; Malinovsky VK; Ogienko AG; Drebushchak VA; Manakov AY; Ancharov AI; Yunoshev AS; Boldyreva EV
    J Chem Phys; 2012 Aug; 137(6):065103. PubMed ID: 22897314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solute crystallization in mannitol-glycine systems--implications on protein stabilization in freeze-dried formulations.
    Pyne A; Chatterjee K; Suryanarayanan R
    J Pharm Sci; 2003 Nov; 92(11):2272-83. PubMed ID: 14603512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
    Kasraian K; Spitznagel TM; Juneau JA; Yim K
    Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Phosphate Buffered Saline (PBS) in Frozen State and after Freeze-Drying.
    Thorat AA; Suryanarayanan R
    Pharm Res; 2019 May; 36(7):98. PubMed ID: 31087169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.
    Varshney DB; Sundaramurthi P; Kumar S; Shalaev EY; Kang SW; Gatlin LA; Suryanarayanan R
    Pharm Res; 2009 Jul; 26(7):1596-606. PubMed ID: 19326191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partially crystalline systems in lyophilization: I. Use of ternary state diagrams to determine extent of crystallization of bulking agent.
    Chatterjee K; Shalaev EY; Suryanarayanan R
    J Pharm Sci; 2005 Apr; 94(4):798-808. PubMed ID: 15729706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low temperature properties of lyophilized solutions and their influence on lyophilization cycle design: pentamidine isethionate.
    Williams NA; Schwinke DL
    J Pharm Sci Technol; 1994; 48(3):135-9. PubMed ID: 8069514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents.
    Wittaya-Areekul S; Nail SL
    J Pharm Sci; 1998 Apr; 87(4):491-5. PubMed ID: 9548903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the crystallization propensity of carboxylic acid buffers in frozen systems--relevance to freeze-drying.
    Sundaramurthi P; Suryanarayanan R
    J Pharm Sci; 2011 Apr; 100(4):1288-93. PubMed ID: 24081466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of additives on the crystallization of cefazolin sodium during freeze-drying.
    Pyne A; Suryanarayanan R
    Pharm Res; 2003 Feb; 20(2):283-91. PubMed ID: 12636169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems.
    Pikal-Cleland KA; Cleland JL; Anchordoquy TJ; Carpenter JF
    J Pharm Sci; 2002 Sep; 91(9):1969-79. PubMed ID: 12210044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physical state of nafcillin sodium in frozen aqueous solutions and freeze-dried powders.
    Milton N; Nail SL
    Pharm Dev Technol; 1996 Oct; 1(3):269-77. PubMed ID: 9552309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.